Forty Seven Inc.

The momentum for this stock is not very good. Forty Seven Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Forty Seven Inc..
Log in to see more information.
Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G...

News